教育经历
2003.09–2007.06 山东大学化学与化工学院,本科
2007.09–2012.06 山东大学化学与化工学院,硕博连读
2010.09–2011.09 法国巴黎高师化学系联合培养,博士
工作经历
2012.12–2015.9 苏黎世联邦理工学院,博士后
2015.09–2018.11 复旦大学药学院药剂学教研室,青年副研究员
2018.12–今 复旦大学药学院药剂学教研室,副教授
专家类别
副教授
承担科研项目情况
1. 瑞士诺华集团博士后研究基金(主持,2012-2015,结题)
2. 复旦大学引进人才科研基金(主持,2015-2018,结题)
3. 上海市青年科技英才扬帆计划基金(主持,2016-2019,结题)
4. 复旦大学老年医学专项支持计划青年学者创新研究项目(主持,2016-2018,结题)
5. 国家自然科学基金青年科学基金项目(主持,2016-2019,结题)
6. 智能化递药教育部重点实验室开放课题(主持,2016-2018,结题)
7. 复旦大学附属中山医院闵行分院-复旦大学药学院战略合作研究融合基金(主持,2017-2019,结题)
8. 复旦大学药学院-上海药物所合作研究课题融合基金(主持,2018-2021,在研)
9. 复旦大学2025卓学计划基金(主持,2020-2025,在研)
10. 上海人社上海人才发展资金(主持,2021-2022,在研)
11. 国家自然科学基金“肿瘤演进与诊疗的分子功能可视化”研究重大研究计划,培育项目(主持,2021-2023,在研)
获奖及荣誉
2020年 英国皇家化学会,新锐科学家
2019年 全国高校药学类青年教师教学能力大赛,特等奖
2019年 全国高校药学类青年教师微课教学大赛,一等奖
2019年 上海药学会药剂学年会论文报告会,二等奖
2019年 复旦大学上海医学院第二届课程思政教案大赛,三等奖
2018年 美国药剂师协会年会,Best Abstract
2018年 上海药学会药剂学年会论文报告会,优胜奖
2018年 复旦大学德传奖教金
2015年 第十届中国海外留学人员春晖杯竞赛优胜奖
2012年 山东大学优秀毕业生,山东省优秀毕业生
2010年 中国大学生“挑战杯”创业计划竞赛,省级特等奖,国家级银奖
2009年 第十一届“挑战杯”全国大学生课外学术科技作品竞赛,省级特等奖,国家级二等奖
2009年来, 以通讯/第一作者身份,在国际重要学术期刊上发表多篇SCI论文, 包括ACS Nano, Nano Lett., Biomaterials, J. Control. Release, ACS Appl. Mater. Interfaces, Chem. Commun.等30余篇, 共被引用逾1200次,H因子21。近年代表性论文如下:
23. C. Li, C. Jiang,* T. Sun.* Recent advances in nanomedicines for the treatment of ischemic stroke. Acta Pharmaceutica Sinica B, 2021, https://doi.org/10.1016/j.apsb.2020.11.019.
22. C. Li,# Z. Xie,# Q. Chen, Y, Zhang, Y. Chu, Q. Guo, W. Zhou, Y. Zhang, P. Liu, H. Chen, C. Jiang,* K. Sun,* T. Sun.* Supramolecular Hunter Stationed on Red Blood Cells for Detoxification Based on Specific Molecular Recognition. ACS Nano, 2020, 14, 4950-4962.
21. T. Sun, Y. Ding, X. Wang, K. Zhang, G.-P. Zhang, D. Liang, K. Yu, Y. Chu, Q. Chen, C. Jiang.* Carry-On Nitric-Oxide-Luggage for Enhanced Chemotherapeutic Efficacy. Nnao Letters, 2020, 20, 5275-5283.
20. T. Sun, G. Zhang, Z. Guo, Q. Chen, Y. Zhang, Y. Chu, Q. Guo, C. Li, W. Zhou, Y. Zhang, P. Liu, H. Chen, H. Yu, L. Jiang, C. Jiang.* Co-delivery of Cu (I) chelator and chemotherapeutics as a new strategy fortumor theranostic. Journal of Controlled Release, 2020, 321, 483-496.
19. Q. Wang, X. Guo, Y. Chen, Z. Wu, Y. Zhou, S. Sadaf, L. Han, X. Ding,* T. Sun.* Theranostics system caged in human serum albumin as a therapy for breast tumors, Journal of Materials Chemistry B, 2020, 8, 6877-6885 (Invited paper).
18. D. Gao, Q. Zhu, J. Ruan, T. Sun,* L. Han.* Polyplexes by polymerized dequalinium and bi-functional aptamer for mitochondrial targeting drug release to overcome drug resistance. ACS Applied Bio Materials, 2020, 3, 8, 5182-5192.
17. T. Sun, G. Zhang, Q. Wang, Z. Guo, Q. Chen, X. Chen, Y. Lu, Y. Zhang, Y. Zhang, Q. Guo, X. Gao, Y. Cheng, C. Jiang*, Pre-blocked molecular shuttle as an in-situ real-time theranostics, Biomaterials, 2019, 204, 46-58.
16. T. Sun, G. Zhang, Q. Wang, Q. Chen, X. Chen, Y. Lu, L. Liu, Y. Zhang, X. He, C. Ruan, Y. Zhang, Q. Guo, C. Jiang*, A targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion, Biomaterials, 2018, 183, 268-279.
15. C. Ruan, L. Liu, Q. Wang, X. Chen, Q. Chen, Y. Lu, Y. Zhang, X. He, Y. Zhang, Q. Guo, T. Sun,* C. Jiang, Reactive Oxygen Species-Biodegradable Gene Carrier for the Targeting Therapy of Breast Cancer, ACS Applied Materials & Interfaces, 2018, 10, 10398-10408.
14. C. Ruan, L. Liu, Y. Lu, Y. Zhang, X. He, X. Chen, Y. Zhang, Q. Chen, Q. Guo, T. Sun,* C. Jiang, Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma, Acta Pharmaceutica Sinica B, 2018, 8(1), 85-96.
13. T. Sun, X. Jiang, Q. Wang, Q. Chen, Y. Lu, L. Liu, Y. Zhang, X. He, C. Ruan, Y. Zhang, Q. Guo, Y. Liu, C. Jiang*, Substance P Mediated DGLs Complexing with DACHPt for Targeting Therapy of Glioma, ACS Applied Materials & Interfaces, 2017, 9, 34603-34617.
12. T. Sun, Q. Wang, Y. Bi, X. Chen, L. Liu, C. Ruan, Z. Zhao, C. Jiang*, Supramolecular amphiphiles based on cyclodextrin and hydrophobic drugs, Journal of Materials Chemistry B, 2017, 5, 2644-2654.
11. T. Sun, L. Shu, J. Shen, C. Ruan, Z. Zhao, C. Jiang*, Photo and redox-responsive vesicles assembledfrom Bola-type superamphiphiles, RSC Advances, 2016, 6, 52189-52200.
10. T. Sun, A. Morger, B. Castagner*, J.-C. Leroux*, An oral redox-sensitive self-immolating prodrug strategy, Chemical Communications, 2015, 51, 5721-5724.
9. T. Sun, H. Yan, P. Xing, J. Su, S. Li, A. Hao*, Cu (II)-triggered release of paclitaxel from a supramolecular complex, Supramolecular Chemistry, 2013, 25 (5), 302-3095.
8. T. Sun, M. Ma, H. Yan, J. Shen, J. Su, A. Hao*, Vesicular particles directly assembled from the cyclodextrin/UR-144 supramolecular amphiphiles, Colloids and Surface A, 2013, 424, 105-1126.
7. P. Xing#, T. Sun#, A. Hao*, Vesicles from supramolecular amphiphiles, RSC Advances, 2013, 3 (47), 24776-24793 (#co-first authors)
6. T. Sun, Q. Guo, C. Zhang, J. Hao, P. Xing, J. Su, S. Li, A. Hao*, G. Liu*, Vesicles with functional macrocyclic host sites confined in the bilayer as drug carriers, Langmuir, 2012, 28, 8625-8636.
5. T. Sun, H. Yan, G. Liu, J. Hao, J. Su, S. Li, P. Xing, A. Hao*, Strategy of directly employing paclitaxel to construct vesicles, Journal of Physical Chemistry B, 2012, 116 (50), 14628-14636.
4. T. Sun, J. Shen, H. Yan, J. Hao, A. Hao*, Stable vesicles assembled by “supramolecular amphiphiles” with double hydrophobic chains, Colloids and Surface A, 2012, 414, 41-49.
3. T. Sun, Y. Li, H. Zhang, J. Li, F. Xin, L. Kong, A. Hao*, pH-reversible vesicles based on the "supramolecular amphiphilies" formed by cyclodextrin and anthraquinone derivate, Colloids and Surface A, 2011, 375, 87-96.
2. T. Sun, H. Zhang, L. Kong, H. Qiao, Y. Li, F. Xin, A. Hao*, Controlled transformation from nanorods to vesicles induced by cyclomaltoheptaoses (β-cyclodextrins), Carbohydrate Research, 2011, 346, 285-293.
1. T. Sun#, H. Zhang#, H. Yan, J. Li, G. Cheng, A. Hao*, H.Qiao, F. Xin, Sensitive fluorescent vesicles based on the supramolecular inclusion of β-cyclodextrin with N-alkylamino-1-anthraquinone, Supramolecular Chemistry, 2011, 23(5), 351-364 (#co-first authors).